I remember last year, when we were looking at estimates, one of the biggest areas of growth was the Patented Medicine Prices Review Board. I notice there doesn't appear to be changes this year. Were you satisfied in the last year with how their increase was utilized? I remember there were several questions around the table last year when we did the supplementary estimates.
On December 2nd, 2009. See this statement in context.